Search Within

Maria E Caldas Lopes- Vazquez

Formats
  1. Meeting Abstract (25)
  2. Journal Article (14)
Groups
  1. Sloan Kettering Institute Faculty (38)
  2. Center for Hematologic Malignancies (33)
  3. GSK Faculty (33)
  4. Hematologic Malignancies Research (33)
  5. Molecular Pharmacology and Chemistry Program Faculty (33)
  6. Sloan Kettering Institute Postdocs (22)

More Groups

People
  1. Gabriela Chiosis (33)
  2. Tony Taldone (18)
  3. Anna Rodina Balingcongan (13)
  4. Malcolm Moore (10)
  5. Jason Lewis (9)
  6. Srikanth Ambati (9)

More People

Years
  1. 2019 (1)
  2. 2016 (2)
  3. 2015 (4)
  4. 2014 (4)
  5. 2013 (3)
  6. 2012 (3)

More Years

Publications
  1. Cancer Research (12)
  2. Blood (7)
  3. Journal of Clinical Investigation (2)
  4. Abstracts of Papers of the American Chemical Society (1)
  5. Annals of Oncology (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. American Society of Hematology (7)
  3. Nature Publishing Group (3)
  4. American Society for Clinical Investigation (2)
  5. Cell Press (2)
  6. American Chemical Society (1)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • The epichaperome is an integrated chaperome network that facilitates tumour survival
    Journal Article

    Rodina, A.; Wang, T.; Yan, P.; Gomes, E. D.; Dunphy, M. P. S.; Pillarsetty, N.; Koren, J. 3rd; Gerecitano, J. F.; Taldone, T.; Zong, H.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models
    Journal Article

    Ambati, S. R.; Shieh, J. H.; Pera, B.; Lopes, E. C.; Chaudhry, A.; Wong, E. W.; Saxena, A.; Su, T. L.; Moore, M. A.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • A hyperactive signalosome in acute myeloid leukemia drives addiction to a tumor-specific Hsp90 species
    Journal Article

    Zong, H.; Gozman, A.; Caldas-Lopes, E.; Taldone, T.; Sturgill, E.; Brennan, S.; Ochiana, S. O.; Gomes-DaGama, E. M.; Sen, S.; Rodina, A.; more...
    Cell Reports (2015)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Ureidomustine, a novel DNA-crosslinking agent shows activity in sarcoma preclinical models and lacks toxicity in normal tissues
    Meeting Abstract

    Ambati, S. R.; Shieh, J.; Pera, B.; Wong, E. W. P.; Lopes, E. C.; Peguero, E.; Su, T. L.; Moore, M. A. S.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity
    Meeting Abstract

    Lopes, E. C.; Shieh, J. H.; Ambati, S.; Tsann-Long, S.; Correa, F.; Peguero, E.; Moore, M. A. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Pre-clinical evaluation of a novel DNA crosslinking agent, Ureidomustin (BO-1055) in pediatric sarcomas
    Meeting Abstract

    Ambati, S. R.; Wong, E. W.; Pera, B.; Peguero, E.; Lopes, E. C.; Chen, J. J.; Shieh, J.H.; Su, T. L.; Moore, M. A.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Characterization of DLBCL-derived exosomes and investigation of their biological properties
    Meeting Abstract

    Rutherford, S. C.; Sawh, S.; Saxena, A.; Ishii, J.; Dominguez, M. D.; Chambwe, N.; Lopes, E. C.; Agirre, X.; Betel, D.; Shaknovich, R.
    Blood (2014)

    Fulltext@MSK | Save
  • Pre-clinical evaluation of a novel DNA crosslinking agent, BO-1055 in B-cell lymphoma
    Meeting Abstract

    Lopes, E. C.; Correa, F.; Peguero, E.; Ambati, S. R.; Shieh, J.H.; Su, T. L.; Moore, M. A. S.
    Blood (2014)

    Fulltext@MSK | Save